Diagnosing overactive immune response in ICU patients
Part of Digestive system clinical trials.
This study is looking at patients who were in the intensive care unit and showed signs of a condition called HLH, where the immune system becomes overactive. Researchers want to understand how these signs were diagnosed and managed in the ICU.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were 18 or older when in the ICU.
- You were in the ICU at Hautepierre Hospital, Strasbourg, between January 2014 and December 2024.
- You had at least three signs of HLH: very high ferritin, high triglycerides, or low blood counts (low white blood cells, low platelets, or low hemoglobin).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people with hemophagocytic lymphohistiocytosis (HLH), a condition where the immune system becomes overactive. Researchers want to collect medical data and blood samples to better understand HLH and find better ways to diagnose and treat it.
This trial looks at how people with lymphoma-related hemophagocytic lymphohistiocytosis (HLH) respond to treatment. It aims to better describe expected outcomes and who benefits most, which may help guide future care.
This study aims to create an early warning system to identify patients with hemophagocytic lymphohistiocytosis (HLH), a rare but serious immune overreaction. If you have certain infections, autoimmune diseases, or lymphoma, this screening could help detect HLH early.
This is a research study collecting information and blood samples from patients with autoimmune hepatitis (a condition where the immune system attacks the liver) and patients with other types of liver disease. The goal is to better understand how these diseases develop and find new ways to diagnose and treat them.
This study follows adults who have findings that suggest HLH, a serious immune problem. It may help doctors better understand the condition by tracking patients over time and comparing symptoms and test results.
This trial studies whether giving high-dose cyclophosphamide as an initial treatment works better for adults with HLH. HLH is a serious, overactive immune condition, and the study aims to improve control of the illness and safety.
Hear when a new Hepatic Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.